Easterly Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$115M |
| 2 |
RTX Corp
RTX
|
+$107M |
| 3 |
AbbVie
ABBV
|
+$99.6M |
| 4 |
Williams Companies
WMB
|
+$67.9M |
| 5 |
CenterPoint Energy
CNP
|
+$61.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$120M |
| 2 |
Pfizer
PFE
|
+$114M |
| 3 |
JPMorgan Chase
JPM
|
+$84M |
| 4 |
Apple
AAPL
|
+$82.1M |
| 5 |
AT&T
T
|
+$72.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.3% |
| 2 | Consumer Staples | 17.95% |
| 3 | Healthcare | 12.28% |
| 4 | Technology | 11.95% |
| 5 | Energy | 8.45% |
Similar funds
Easterly Investment Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Easterly Investment Partners held 112 positions worth $3.56B, down 11% from $3.98B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Easterly Investment Partners withdrew a net $346M in Q3 2019, closing 23 positions and reducing 32 holdings. Its most notable exit was Dow Inc, an estimated $59.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Easterly Investment Partners opened a new position in RTX Corp worth $111M.
- Easterly Investment Partners's largest Q3 2019 buy was RTX Corp: 1,286,671 shares worth $111M.
- Easterly Investment Partners added most to Morgan Stanley in Q3 2019, an estimated $115M increase.
- Easterly Investment Partners's biggest Q3 2019 reduction was Bio-Rad Laboratories Class A, cutting an estimated $120M.
- Easterly Investment Partners fully exited Dow Inc in Q3 2019, selling an estimated $59.9M.
- Easterly Investment Partners's ten largest holdings make up 46% of its $3.56B portfolio in Q3 2019.
- Easterly Investment Partners opened 20 new positions and closed 23 in Q3 2019.
- Easterly Investment Partners's portfolio value fell 11% quarter-over-quarter to $3.56B.
Based on Easterly Investment Partners's 13F filing for Q3 2019, filed 14 Nov 2019.